Three months after the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) announced their intent to schedule 7-hydroxymitragynine (7-OH), a naturally occurring alkaloid derived from kratom, the number of confirmed deaths linked exclusively to 7-OH remains zero.
Despite repeated claims suggesting imminent danger, no data has ever been presented to show that 7-OH poses any public health threat warranting emergency scheduling. Instead, the agencies’ actions appear to disregard the lived experiences of thousands of Americans who use 7-OH responsibly to manage pain, improve focus, and support overall well-being.
Jeff Smith, Ph.D., national policy director of the Holistic Alternative Recovery Trust (HART), issued the following statement:
“What facts drove the recommendation from HHS? None. No evidence was presented in August or over the past 3 months. Not a single study. Not one data point specific to 7-OH.
If 7-OH posed the kind of urgent danger that would justify emergency action, evidence would have been presented. It was not. When a reporter asked if the government could attribute even a single death to 7-OH, no official was able to do so. Rather, a woman who admitted she had never tried 7-OH was trotted out to claim that it was dangerous…based on what she said another customer told her vape shop clerk.
While stating that doctors don’t know what 7-OH is or how to check for it, HHS also claimed there is an epidemic of people dying from it. Where is the data showing this?
Let’s be clear: 7-OH is not a public health crisis. According to the Food and Drug Administration’s (FDA) own Adverse Event Reporting System (FAERS), there have been under 40 adverse events ever reported, after well over a billion doses consumed nationwide."
Smith added that HART continues to call for evidence-based policymaking and open scientific review before any action is taken that could harm consumers, researchers, and small businesses operating within the legal botanical products industry.
“The American people deserve transparency, scientific integrity, and consumer choice,” Smith added. “The scheduling of 7-OH is a dangerous precedent. It tells consumers their health takes a back seat to corporate lobbying. It tells researchers their work will be evaluated in the policymaking sphere based on politics, not evidence. And it tells patients seeking safer alternatives that Washington would rather push them into the shadows than allow regulated, legal access.”
About Holistic Alternative Recovery Trust (HART)
The Holistic Alternative Recovery Trust (HART) is a nonprofit policy organization dedicated to advancing safe, evidence-based access to natural alternatives for recovery and wellness. HART advocates for scientific transparency, consumer safety, and regulatory accountability in emerging health and wellness industries. Learn more at hartsupporter.com.
Media Contact
HART Media
media@hartsupporter.com
